Use access key #2 to skip to page content.
$15.85 -1.32 (-7.69%)
10/6/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

0

Avatar mgbinsd (< 20) Submitted: 11/16/06 1:06 PM : Outperform Start Price: $44.37 AMLN Score: -38.62

Company continues to have very good results on not only their FDA approved drugs, but their pipeline drugs as well.

Report this Post Replies: 0 | Reply

Featured Broker Partners